The role of apolipoprotein processing in receptor recognition of VLDL.
D000818:Animals; D001053:Apolipoproteins / Q000235:genetics*; D002478:Cells, Cultured; D002501:Centrifugation, Zonal / Q000379:methods; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007202:Indicators and Reagents; D007700:Kinetics; D008079:Lipoproteins, VLDL / Q000097:blood / Q000302:isolation & purification / Q000378:metabolism*; D011499:Protein Processing, Post-Translational; D011973:Receptors, LDL / Q000378:metabolism*; D012867:Skin / Q000378:metabolism
D001053:Apolipoproteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007202:Indicators and Reagents; D008079:Lipoproteins, VLDL; D011973:Receptors, LDL; C036053:VLDL receptor